|2.||Anxiety Disorders (Anxiety Disorder)
|3.||Eating Disorders (Eating Disorder)
|4.||Bulimia (Binge Eating)
|5.||Weight Loss (Weight Reduction)
|1.||Kaye, Walter H: 21 articles (12/2015 - 02/2003)|
|2.||de Zwaan, Martina: 19 articles (11/2015 - 05/2003)|
|3.||Mitchell, James E: 18 articles (03/2015 - 04/2002)|
|4.||Bulik, Cynthia M: 17 articles (01/2015 - 01/2002)|
|5.||Treasure, Janet: 16 articles (01/2015 - 10/2002)|
|6.||Ricca, Valdo: 16 articles (11/2014 - 04/2002)|
|7.||Grilo, Carlos M: 15 articles (05/2013 - 03/2002)|
|8.||Steiger, Howard: 14 articles (07/2015 - 01/2004)|
|9.||Monteleone, Palmiero: 11 articles (01/2016 - 11/2002)|
|10.||Iyo, Masaomi: 11 articles (01/2013 - 08/2003)|
01/01/2006 - "Cognitive-behavioral therapy has been effective in treating alcohol use and eating disorders individually and may be an effective combined treatment for co-morbid eating disorders and alcohol use. "
03/01/1997 - "Laboratory findings obtained at the initial examination may be helpful in predicting a fatal or chronic course of AN. An evaluation of the long-term outcome of eating disorders should include an assessment of the medical co-morbidity."
08/01/2013 - "The purpose of this study was to examine the co-occurrence of ADHD with clinical eating disorders and disordered eating behaviors in a nationally representative sample via a secondary data analysis of data from the National Longitudinal Study of Adolescent Health (n = 4,862; 2,243 males; 2,619 females). "
01/01/2013 - "The purpose of this study was to determine the prevalence of eating disorders (EDs) in the Sivas province, and to identify the sociodemographic characteristics and co-morbid axis-I and axis-II diagnoses in EDs. "
04/01/2012 - "The current study examines whether such activities are uniquely linked to depressive symptoms versus symptoms of other disorders (including anxiety, externalizing, and eating disorders), and whether co-occurring symptoms more precisely account for the association between depressive symptoms and romantic involvement. "
|2.||Serotonin (5 Hydroxytryptamine)IBA
02/01/1989 - "Drugs interacting with 5-HT systems show promise for treatment of eating disorders."
09/01/2000 - "Several recent studies have pointed to a dysfunction of serotonin transmission in patients with eating disorders. "
03/01/2000 - "The involvement of brain serotonin systems in the pathophysiology of eating disorders has been repeatedly demonstrated in recent studies. "
02/07/2000 - "Previous studies have demonstrated aberrant expression of serotonin in individuals with an eating disorder. "
01/01/1991 - "In this ongoing study, serotonin-mediated physiological responses and whole-blood serotonin content are measured in young women with an eating disorder during the active phase of the illness and at the conclusion of inpatient treatment. "
|3.||Antidepressive Agents (Antidepressants)IBA
01/01/1998 - "Second, use of EMDR may prevent or delay other therapies of established efficacy for eating disorders, such as cognitive behavioral therapy and antidepressants. "
01/01/2006 - "The aim of this review was to evaluate the efficacy and acceptability of antidepressant drugs in the treatment of acute AN. The strategy comprised of database searches of the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register, MEDLINE (1966 to April 28th, 2005), EMBASE (1980 to week 36, 2004), PsycINFO (1969 to August week 5, 2004), handsearching the International Journal of Eating Disorders and searching the reference lists of all papers selected. "
05/01/2001 - "Control trials show that antidepressants are efficacious in eating disorders. "
01/01/1997 - "The effectiveness of antidepressants in males with eating disorders (compared with that in females) has not been well studied. "
06/26/1993 - "Based on scientific results and long therapeutic experience, the author indicates which antidepressants may be more successful in which depression (retarded depression, agitated depression, delusional depression, suicidal ideas, anxiety, obsessive compulsive symptoms, eating disorders and atypical depression)."
|4.||olanzapine (Zyprexa)FDA Link
11/01/2004 - "Olanzapine administration was associated with a significant reduction in depression, anxiety, and core eating disorder symptoms, and a significant increase in weight. "
03/01/2003 - "Subjects reported a significant reduction in anxiety, difficulty eating, and core eating disorder symptoms after taking olanzapine. "
01/01/2007 - "Case reports and trials identified additional benefits of olanzapine, including reduction in delusional thinking; improvement in body image, sleep, depressive symptoms, adherence to treatment, and eating-disorder symptoms; and decreased agitation and premeal anxiety. "
06/01/2011 - "Olanzapine has been recently tried to relieve anxiety and hyperactivity in adolescents with eating disorders (EDs). "
06/01/2011 - "No unexpected adverse events and biochemical side effects of olanzapine as adjunct treatment in adolescent girls with eating disorders."
|5.||topiramate (Topamax)FDA LinkGeneric
05/01/2003 - "Topiramate was added to other psychotropic medication under open-label conditions up to the maximum tolerated dose or until remission of the eating disorder was achieved. "
01/01/2009 - "Topiramate may also have beneficial effects in night-eating syndrome and sleep-related eating disorder, but controlled trials in these conditions are needed. "
11/01/2006 - "Further controlled trials are necessary to establish topiramate's place in therapy, optimal dosing, and length of treatment for this eating disorder."
05/01/2015 - "This case series comprises 7 adolescent patients in whom serious eating disorders developed or were exacerbated after the initiation of topiramate therapy. "
05/01/2015 - "The development or exacerbation of eating disorder symptoms after topiramate initiation."
|6.||Insulin (Novolin)FDA Link
01/01/2014 - "The study found higher dropout rates from therapy in individuals with T1DM and worse treatment outcome in spite of having no significant differences in eating disorder psychopathology, although individuals with T1DM report misusing insulin. "
12/01/2002 - "Recent studies indicate that subclinical eating disorders occur in at least 5% of women and up to 1/3 of females among special populations such as athletes and insulin-dependent diabetics. "
01/01/1996 - "This study examines the prevalence of complications and the usefulness of the Eating Attitudes Test (EAT) in screening for eating disorders in a group of insulin-dependent diabetic women. "
01/01/2016 - "To explore associations between metabolic control (measured by HbA1c) and eating disorder psychopathology, coping strategies, illness perceptions, and insulin beliefs in adolescents with type 1 diabetes. "
11/01/2015 - "Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology."
01/01/1990 - "In this study, 200 women with a mean age of 27.6 years completed the BES, the Eating Disorder Inventory, the Self-Consciousness Scale, the Tennessee Self-Concept Scale, a figure rating task, a phototechnical body-size estimation procedure, and items concerning weight satisfaction and attractiveness. "
08/01/2015 - "A sample of 1008 participants was collected to conduct a confirmatory factor analysis and test the BES psychometric properties; 150 participants were further evaluated through the Eating Disorder Examination 16.0D to assess the discriminant validity of the BES. "
09/01/2010 - "Moreover, patients who have disclosed traumatic episodes (11.7%) presented higher distress associated to eating disorder variables, such as BES (p=0.001) and EDI-2 BU scores (p=0.000) and presence of BED (p=0.001), and women are more likely to be in this group (p=0.043). "
09/01/2010 - "A total of 28.8% of the participants reported a BED; those patients do not differ in BMI (p=0.437) from non-BED patients but had higher psychological disorders associated to eating disorder, as for example Bulimic symptoms (p=0.000), higher BES scores (p=0.000) and psychological distress, such as Depression (p=0.000). "
01/01/1990 - "Results support the construct validity of the BES female subscales and their utility for research in populations at increased risk for body-image or eating-disorder disturbances."
|8.||Fluoxetine (Prozac)FDA LinkGeneric
05/01/2015 - "Fluoxetine remains the only medication approved for an eating disorder, that being BN. "
04/01/2007 - "Fluoxetine in posttraumatic eating disorder in two-year-old twins."
01/01/2000 - "As a result of insufficiency of serotoninergic system of brain in pathogenesis of such disorders, fluoxetine (prozac)-a selective inhibitor of serotonine reuptake--was used for treatment of eating disorders. "
09/01/1999 - "Fluoxetine and eating disorders."
08/01/1997 - "In some respects, the fluoxetine group did slightly better as demonstrated by the items 'restraint', 'weight concern' and 'shape concern' (p < 0.05 vs p < 0.0001) on the Eating Disorder Examination (EDE). "
|9.||Fluvoxamine (Luvox)FDA LinkGeneric
04/01/2003 - "A significant reduction in binge frequency, Beck Depression Inventory scores and the eating concern, shape concern and weight concern subscales of the Eating Disorder Examination were noted for both fluvoxamine (n = 9) and placebo (n = 11) groups. "
05/01/1993 - "However, the results indicate that Fluvoxamine may have a role in the treatment of eating disorders where bingeing is a prominent symptom and that further research would be valuable. "
05/01/1993 - "Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing."
10/01/2000 - "In addition, treatment with fluvoxamine < or = 300 mg/day for > or = 8 weeks improved symptoms of social phobia (social anxiety disorder), post-traumatic stress disorder (PTSD), pathological gambling, compulsive buying, trichotillomania, kleptomania, body dysmorphic disorder, eating disorders and autistic disorder. "
02/01/1996 - "In both the intent-to-treat and the completer analyses, the following scales showed fluvoxamine to have a significant effect in reducing the return of bulimic behavior: (1) self-ratings: Eating Disorder Inventory (EDI)-bulimia, urges to binge in previous week and the number of actual binges in the previous week; (2) expert ratings: Psychiatric Status Rating Scales for Bulimia nervosa, Structured Interview for Anorexia and Bulimia nervosa (SIAB)-"total score," SIAB-subscale "fasting," and SIAB-subscale "vomiting." Two further variables (EDI-total score and SIAB-subscale "bulimia") showed the superior relapse prevention effects of fluvoxamine compared with placebo for the completer sample, while they did not reach significance for group-by-time interactions in the intent-to-treat sample. "
|10.||Levodopa (L Dopa)FDA LinkGeneric
03/01/2010 - "Supplementation with 5-hydroxytryptophan, but not with levodopa, normalized serotonin metabolism in the CSF, reduced sleep time to 540 min, normalized the eating disorder and the melatonin profile, restored a circadian sleep-wake rhythm (sleep occurred every 24 +/- 1.7 h, P < 0.0001), and improved cognition. "
11/01/2009 - "Therefore, dopamine supplement drugs (e.g., L-dopa or amantadine hydrochloride), and agents to block substance P degradation (e.g., angiotensin-converting enzyme) are effective in the treatment of eating disorders. "
12/01/2007 - "We report the medical workup, treatment, and outcomes in a 19-year old female patient who developed Raynaud's phenomenon following the onset of AN. After treatment with nutritional rehabilitation, counseling, and individual and group therapy, the patient's weight, eating disorder-related behaviors, and attitudes improved significantly. "
01/01/2000 - "This study assessed family perception patterns of interpersonal behavior in families with a daughter diagnosed with an eating disorder 6 years after treatment that used a prospective design. "
12/01/2015 - "Patients were assessed before and after treatment using not only a food and binging/purging diary and clinical questionnaires in the field of eating disorders but also additional indexes for measuring anger expression and anxiety. "
06/01/2015 - "Measures of eating disorder psychopathology continued to improve up to a year after treatment. "
06/01/2015 - "The prevalence of orthorexia nervosa among eating disorder patients after treatment."
|2.||Drug Therapy (Chemotherapy)
05/01/2006 - "Although these compounds are in early phases of clinical testing for eating disorder treatments, data from these studies will be instructive in the quest for effective pharmacotherapy for these conditions. "
10/01/2005 - "Positron emission tomography studies in eating disorders: multireceptor brain imaging, correlates with behavior and implications for pharmacotherapy."
05/01/2015 - "There remains a disconnection between the size of eating disorders as a public health problem and the lack of pharmacotherapy research of these conditions."
07/01/2013 - "To provide a comprehensive review of pharmacotherapy and other biological treatments for eating disorders. "
03/01/2012 - "The objective was to review scientific evidence for efficacy and safety of pharmacotherapy in adults or children with an eating disorder (ED). "
|3.||Deep Brain Stimulation
05/01/2010 - "Deep brain stimulation in the subgenual cingulate cortex for an intractable eating disorder."
05/15/2013 - "Deep Brain Stimulation (DBS) is a successful novel treatment for treatment-resistant obsessive-compulsive disorder and is currently under investigation for addiction and eating disorders. "
01/01/2013 - "Deep brain stimulation (DBS) of the nucleus accumbens (NAc) is an effective therapy for obsessive compulsive disorder (OCD) and is currently under investigation as a treatment for eating disorders. "
01/01/2012 - "Following the successful application of deep brain stimulation (DBS) in the treatment of Parkinson's disease and promising results in clinical trials for obsessive compulsive disorder and major depression, DBS is currently being tested in small patient-populations with eating disorders and addiction. "
05/01/2003 - "Although use of deep brain stimulation for applications beyond movement disorders will no doubt involve placing the stimulating electrode(s) in regions other than the thalamus, subthalamus, or globus pallidus, the use of vagus nerve stimulation for applications beyond epilepsy-for example, depression and eating disorders-is unlikely to require altering the hardware significantly (although stimulation protocols may differ). "
07/01/2007 - "Research on the efficacy of hypnosis in the treatment of eating disorders has produced mixed findings. "
04/01/2010 - "Prior treatment of eating disorders using hypnosis is reviewed. "
07/01/2007 - "This is due in part to the interplay between the characteristics of people with eating disorders and the phenomena of hypnosis. "
09/01/2003 - "Eating disorders: the role of hypnosis."
01/01/1992 - "This paper reviews the literature on the use of hypnosis in the assessment and treatment of eating disorders. "
|5.||Nutrition Therapy (Medical Nutrition Therapy)
04/01/2010 - "Training and experience in nutrition therapy specific to eating disorders promote a positive outcome in patients. "
04/01/2010 - "Additional research is needed to delineate the most effective strategies for nutrition therapy in the treatment of eating disorders."
04/01/2010 - "This review provides an overview of the current state of the art in the practice of nutrition therapy for eating disorders, providing guidance in nutrition assessment, interventions, monitoring and interpretation of information and data, awareness of emerging roles for nutrition, and important considerations regarding professional boundaries practiced in the field of eating disorders. "
04/01/2010 - "Nutrition therapy for eating disorders."
07/01/2001 - "Medical Nutrition Therapy provided by a registered dietitian trained in the area of eating disorders plays a significant role in the treatment and management of eating disorders. "